GlassScriptPhysician profile
Alexander Michael Demare
NPI 1306224811
$3,555.71
in general payments reported to CMS, 2019-2025
11 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.39 · 2020: $144 · 2021: $403 · 2022: $347 · 2023: $1,049 · 2024: $1,261 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556 · Education: $1,000 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.49 |
| Education | $1,000.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,831.61 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Angiodynamics, INC. | $403.14 | 2021 | |
| Medtronic, INC. | $242.02 | 2024 | Signia |
| Aimmune Therapeutics, INC. | $203.37 | 2024-2025 | Zenpep |
| Becton, Dickinson and Company | $182.36 | 2025 | Hemosphere |
| Dilon Technologies, INC. | $181.91 | 2024 | Hemoblast Bellows |
| Boston Scientific Corporation | $158.90 | 2022 | |
| Integra Lifesciences Corporation | $143.64 | 2020 | |
| Teleflex LLC | $105.25 | 2022 | |
| W. L. Gore & Associates, INC. | $83.16 | 2022 | |
| Ethicon US, LLC | $20.35 | 2023 | Surgicel Nu-Knit, Harmonic, Enseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Demare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.